Identification of novel regulators of HSC specification and maturation
HSC 规范和成熟的新型调节剂的鉴定
基本信息
- 批准号:10356477
- 负责人:
- 金额:$ 28.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-23 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:Biological AssayBloodCRISPR/Cas technologyCandidate Disease GeneCellsClinicalCompetenceCoupledDataDevelopmentDevelopmental BiologyDissectionEmbryoEmbryonic DevelopmentEndothelial CellsEnvironmentGene ExpressionGenerationsGenesGeneticGoalsHematological DiseaseHematopoiesisHematopoieticHematopoietic Cell ProductionHematopoietic Stem Cell SpecificationHematopoietic Stem Cell TransplantationHematopoietic stem cellsHumanImmunologicsIn SituIn VitroKineticsKnowledgeLaboratoriesLarvaMeasuresMediatingModelingMusMutagenesisNatural regenerationPathway interactionsPatientsPositioning AttributeProcessProductionPropertyPublic HealthRNA ProcessingRegulationReplacement TherapyResearchStem Cell DevelopmentSystemTestingTimeTransplantationZebrafishexperiencehematopoietic stem cell formationhematopoietic stem cell self-renewalhemogenic endotheliumimprovedin vivoinduced pluripotent stem cellnovelnovel strategiesprogenitorprogramsregenerativeself-renewalsingle-cell RNA sequencingstem cellszebrafish development
项目摘要
Identification of novel regulators of HSC specification and maturation
Project Abstract
Hematopoietic stem cells (HSCs) are defined by self-renewal and multilineage differentiation capacities. HSCs
sustain lifelong hematopoiesis and are exploited for hematopoietic transplantation to replace damaged or
diseased blood systems in patients with hematologic disorders. Despite the widespread usage, transplantation
remains unattainable for many due to the paucity of appropriate immunologically matched donors. De novo
production of HSCs from patient-specific induced pluripotent stem cells (iPSCs) has been proposed as a means
to circumvent this problem, but it remains an extremely inefficient process. Current approaches result in the
abundant creation of hematopoietic progenitors that possess limited differentiation abilities and lack sufficient
transplantation capacity. During development, there is simultaneous de novo production of these limited-capacity
progenitors alongside HSCs. One of the major limitations in the field is the inability to distinguish these cells at
the time of formation, which makes it difficult to define the factors distinctly critical for HSC generation. Through
single-cell RNA-sequencing of nascent hematopoietic stem and progenitor cells from developing zebrafish, we
identified genes that discriminate HSCs from progenitors at the time of their formation. We also developed new
in situ lineage-tracing and regenerative assays in zebrafish larvae to define functional differences between the
differentiation kinetics and self-renewal of these cell subsets. Here, we plan to exploit the genetic malleability of
zebrafish coupled with our novel assays to discover new regulators uniquely required for HSC formation. The
SHINE-II mechanism (PAS-18-730) is dedicated to supporting new research directions in their early stages.
Consistent with this aim, this project takes our laboratory in a new direction away from our focus on RNA
processing in hematopoiesis and into the realm of understanding de novo production of bona fide HSCs. Our
experience in zebrafish genetics and developmental biology along with our establishment of new assays to
functionally distinguish nascent HSCs from HSC-independent progenitors make us well-positioned to accomplish
our goal of identifying novel factors that uniquely regulate HSC specification and functional maturation.
Identifying this program will provide fundamental knowledge on the acquisition of self-renewal and multipotency
attributes and could provide guidance to improve ex vivo HSC production from mammalian iPSCs.
鉴定HSC规范和成熟的新调节因子
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Teresa V Bowman其他文献
Teresa V Bowman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Teresa V Bowman', 18)}}的其他基金
Identification of novel regulators of HSC specification and maturation
HSC 规范和成熟的新型调节剂的鉴定
- 批准号:
10665070 - 财政年份:2021
- 资助金额:
$ 28.65万 - 项目类别:
Crosstalk of Splicing and Signaling in HSPC fate choices
HSPC 命运选择中剪接和信号传导的串扰
- 批准号:
9973436 - 财政年份:2020
- 资助金额:
$ 28.65万 - 项目类别:
Crosstalk of Splicing and Signaling in HSPC fate choices
HSPC 命运选择中剪接和信号传导的串扰
- 批准号:
10434965 - 财政年份:2020
- 资助金额:
$ 28.65万 - 项目类别:
Crosstalk of Splicing and Signaling in HSPC fate choices
HSPC 命运选择中剪接和信号传导的串扰
- 批准号:
10330938 - 财政年份:2020
- 资助金额:
$ 28.65万 - 项目类别:
Crosstalk of Splicing and Signaling in HSPC fate choices
HSPC 命运选择中剪接和信号传导的串扰
- 批准号:
10661557 - 财政年份:2020
- 资助金额:
$ 28.65万 - 项目类别:
Splicing and Epigenetics Regulation of Hematopoietic Stem Cells
造血干细胞的剪接和表观遗传学调控
- 批准号:
8769909 - 财政年份:2014
- 资助金额:
$ 28.65万 - 项目类别:
Identification of Regulators of Hematopoietic Stem Cells Using Zebrafish Genetics
利用斑马鱼遗传学鉴定造血干细胞的调节因子
- 批准号:
8326105 - 财政年份:2009
- 资助金额:
$ 28.65万 - 项目类别:
Identification of Regulators of Hematopoietic Stem Cells Using Zebrafish Genetics
利用斑马鱼遗传学鉴定造血干细胞的调节因子
- 批准号:
7771086 - 财政年份:2009
- 资助金额:
$ 28.65万 - 项目类别:
Identification of Regulators of Hematopoietic Stem Cells Using Zebrafish Genetics
利用斑马鱼遗传学鉴定造血干细胞的调节因子
- 批准号:
7938972 - 财政年份:2009
- 资助金额:
$ 28.65万 - 项目类别:
相似海外基金
Open Access Block Award 2024 - NHS Blood and Transplant NHSBT School
2024 年开放获取块奖 - NHS 血液和移植 NHSBT 学校
- 批准号:
EP/Z532551/1 - 财政年份:2024
- 资助金额:
$ 28.65万 - 项目类别:
Research Grant
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 28.65万 - 项目类别:
Fellowship
A cluster randomized controlled trial to evaluate pharmacy-based health promotion program to improve blood pressure control in Bangladesh, India and Pakistan
一项整群随机对照试验,旨在评估孟加拉国、印度和巴基斯坦基于药房的健康促进计划,以改善血压控制
- 批准号:
23K24566 - 财政年份:2024
- 资助金额:
$ 28.65万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
経胸壁心臓超音波のBlood Speckle Imagingを用いた大動脈弓部病変評価の研究
经胸心脏超声血斑成像评价主动脉弓病变的研究
- 批准号:
24K10591 - 财政年份:2024
- 资助金额:
$ 28.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
STTR Phase I: A Completely Non-Toxic Blood Bag That Keeps Blood Healthier, Longer
STTR 第一阶段:完全无毒的血袋,使血液保持更健康、更长久
- 批准号:
2335363 - 财政年份:2024
- 资助金额:
$ 28.65万 - 项目类别:
Standard Grant
How blood vessel stiffness regulates their growth and maintenance
血管硬度如何调节其生长和维持
- 批准号:
DE240101055 - 财政年份:2024
- 资助金额:
$ 28.65万 - 项目类别:
Discovery Early Career Researcher Award
Engaging the over 50s to ensure the sustainability of our blood supply
让 50 多岁的人参与进来,确保我们血液供应的可持续性
- 批准号:
LP220200819 - 财政年份:2024
- 资助金额:
$ 28.65万 - 项目类别:
Linkage Projects
A methodology to connect functionalized gonadal constructs to a chick embryo through mechanically induced blood vessels from an egg
一种通过鸡蛋机械诱导血管将功能化性腺结构连接到鸡胚胎的方法
- 批准号:
24K15741 - 财政年份:2024
- 资助金额:
$ 28.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Applying a Program Science approach for strengthening partnerships and advancing embedded research to optimize public health programming for HIV and sexually transmitted and blood-borne infections among criminalized populations in the Global South
应用计划科学方法来加强伙伴关系并推进嵌入式研究,以优化南半球犯罪人群中针对艾滋病毒、性传播和血源性感染的公共卫生规划
- 批准号:
502554 - 财政年份:2024
- 资助金额:
$ 28.65万 - 项目类别:
Designing and fabricating artificial blood cells for global shortages
设计和制造人造血细胞应对全球短缺
- 批准号:
DE240100236 - 财政年份:2024
- 资助金额:
$ 28.65万 - 项目类别:
Discovery Early Career Researcher Award